Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
Article
Emu, Brinda, Fessel, Jeffrey, Schrader, Shannon et al. (2018). Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
. NEW ENGLAND JOURNAL OF MEDICINE, 379(7), 645-654. 10.1056/NEJMoa1711460
Emu, Brinda, Fessel, Jeffrey, Schrader, Shannon et al. (2018). Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
. NEW ENGLAND JOURNAL OF MEDICINE, 379(7), 645-654. 10.1056/NEJMoa1711460